Edwin DeJesus Selected Research

Edwin DeJesus Research Topics

Disease

39	Infections 12/2022 - 10/2003
13	HIV Infections (HIV Infection) 05/2024 - 08/2004
7	Nausea 01/2020 - 08/2003
4	Headache (Headaches) 10/2021 - 01/2018
3	Viremia 01/2022 - 06/2013
3	Coinfection 01/2020 - 03/2015
3	Virus Diseases (Viral Diseases) 11/2013 - 10/2003
3	Hypersensitivity (Allergy) 09/2006 - 01/2005
2	Injection Site Reaction 01/2024 - 08/2003
2	Weight Gain 01/2020 - 06/2007
2	Chronic Hepatitis C 01/2017 - 01/2016
2	Fibrosis (Cirrhosis) 01/2016 - 03/2015
2	Proteinuria 06/2015 - 10/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 06/2013
2	Dizziness (Lightheadedness) 06/2012 - 08/2003
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2007 - 06/2007
1	Dysbiosis 05/2024
1	COVID-19 12/2021
1	Pain (Aches) 10/2021
1	Drug-Related Side Effects and Adverse Reactions 11/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Hypotension (Low Blood Pressure) 04/2019
1	Pulmonary Arterial Hypertension 04/2019
1	Myocardial Infarction 01/2018
1	Neutropenia 01/2018
1	Renal Colic 01/2018
1	Hepatitis C 11/2017
1	Chronic Hepatitis B 11/2017
1	Urticaria (Hives) 01/2017
1	Angioedema 02/2016
1	Renal Insufficiency (Renal Failure) 06/2015
1	Hepatocellular Carcinoma (Hepatoma) 03/2015
1	Liver Diseases (Liver Disease) 03/2015
1	Persistent Infection 11/2014
1	Necrosis 01/2014
1	Gilbert Disease 01/2014
1	Long Term Adverse Effects 01/2014

Drug/Important Bio-Agent (IBA)

19	Emtricitabine (Emtriva)FDA Link 01/2020 - 01/2006
17	Tenofovir (Viread)FDA Link 01/2020 - 07/2004
11	tenofovir alafenamideIBA 01/2020 - 06/2015
9	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2005
8	CobicistatIBA 01/2020 - 03/2011
8	Ritonavir (Norvir)FDA Link 01/2020 - 05/2006
8	efavirenz (Sustiva)FDA Link 01/2017 - 08/2004
7	elvitegravirIBA 09/2016 - 03/2011
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 01/2005
5	VaccinesIBA 12/2021 - 11/2013
5	Lamivudine (Epivir)FDA Link 01/2021 - 08/2004
5	abacavir (Ziagen)FDA Link 01/2020 - 01/2005
5	TabletsIBA 01/2019 - 03/2011
5	Atazanavir Sulfate (Reyataz)FDA Link 03/2014 - 03/2008
4	NucleosidesIBA 01/2021 - 09/2004
4	bictegravirIBA 01/2020 - 01/2017
4	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 11/2014
4	lamivudine drug combination abacavir FDA Link 11/2006 - 05/2006
4	Zidovudine (Retrovir)FDA LinkGeneric 11/2006 - 08/2004
3	doravirineIBA 01/2021 - 01/2018
3	dolutegravirIBA 01/2020 - 01/2017
3	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2006
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 09/2004
3	SimeprevirIBA 01/2017 - 11/2014
3	RacivirIBA 06/2012 - 05/2012
3	fosamprenavir (Lexiva)FDA Link 03/2008 - 05/2006
2	vesatolimodIBA 05/2024 - 01/2021
2	Darunavir (Prezista)FDA Link 01/2020 - 01/2018
2	CholesterolIBA 01/2020 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 11/2013
2	Rilpivirine (TMC-278)IBA 01/2017 - 01/2017
2	NucleotidesIBA 01/2016 - 09/2004
2	SofosbuvirIBA 01/2016 - 11/2014
2	CreatinineIBA 06/2015 - 10/2008
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 06/2013
2	Enfuvirtide (Fuzeon)FDA Link 12/2008 - 08/2003
2	LipidsIBA 01/2005 - 07/2004
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	ChAdOx1 nCoV-19IBA 12/2021
1	Monoclonal AntibodiesIBA 10/2021
1	islatravirIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	GSK-2838232IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	fostemsavirIBA 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 11/2019
1	Soluble Guanylyl CyclaseIBA 04/2019
1	riociguatIBA 04/2019
1	cobicistat mixture with darunavirIBA 01/2019
1	emtricitabine tenofovir alafenamideIBA 01/2019
1	acivicin (AT 125)IBA 01/2018
1	elbasvirIBA 03/2015
1	grazoprevirIBA 03/2015
1	InterferonsIBA 11/2014
1	UK 453,061IBA 09/2014
1	etravirine (TMC-125)FDA Link 09/2014
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	IDX 899IBA 01/2014

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2006
2	Art Therapy 05/2024 - 06/2013
1	Intravenous Injections 10/2021